Safety and Efficacy of Reduced Dose of Enzalutamide in Patients with Castration-Resistant Prostate Cancer: A Systematic Review

<b>Objective:</b> To review the efficacy and safety of reduced dose compared to standard dose Enzalutamide treatment for patients with castration-resistant prostate cancer (CRPC). <b>Methods:</b> PubMed, Scopus, Web of Science, and Cochrane databases were searched for randomi...

詳細記述

書誌詳細

出版年:	Pharmaceuticals
主要な著者:	Zineddine Belabaci, Lucas Mose, Omar El-Taji, Zina Otmani, Zein Alabdin Hannouneh, Issa Mohamad, Thomas Zilli, Osama Mohamad, Nadeem Pervez, Waleed Arafat, Ursula Vogl, Mohamed Shelan
フォーマット:	論文
言語:	英語
出版事項:	MDPI AG 2025-05-01
主題:	castration-resistant prostate cancer enzalutamide dose efficacy adverse events
オンライン･アクセス:	https://www.mdpi.com/1424-8247/18/5/732